Search results
Showing 406 to 420 of 1003 results for public health medicine & health
Awaiting development Reference number: GID-TA11687 Expected publication date: TBC
Fenebrutinib for treating relapsing multiple sclerosis [ID6577]
Awaiting development Reference number: GID-TA11775 Expected publication date: TBC
Elamipretide for treating Barth syndrome in people of any age [ID6545]
In development Reference number: GID-TA11719 Expected publication date: TBC
Fenebrutinib for treating primary progressive multiple sclerosis [ID6543]
Awaiting development Reference number: GID-TA11721 Expected publication date: TBC
Awaiting development Reference number: GID-TA11342 Expected publication date: TBC
Awaiting development Reference number: GID-TA11085 Expected publication date: TBC
Awaiting development Reference number: GID-TA11094 Expected publication date: TBC
In development Reference number: GID-TA11718 Expected publication date: TBC
Antisocial personality disorder: prevention and management (CG77)
This guideline covers principles for working with people with antisocial personality disorder, including dealing with crises (crisis resolution). It aims to help people with antisocial personality disorder manage feelings of anger, distress, anxiety and depression, and to reduce offending and antisocial behaviour.
Agenda and papers of the NICE public board meeting on 18 September 2025
Advocacy services for adults with health and social care needs (NG227)
This guideline covers advocacy for people using health and social care services in all adult settings (including young people under 18 using adult services). It describes how to commission and deliver effective advocacy, as well as identifying who should be offered advocacy (including who is legally entitled to it). It also covers monitoring and improving advocacy services, and training and skills for advocates and practitioners.
This guideline sets out an antimicrobial prescribing strategy for adults, young people and children aged 72 hours and over with impetigo. It aims to optimise antibiotic use and reduce antibiotic resistance.
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
In development Reference number: GID-TA11036 Expected publication date: TBC
Awaiting development Reference number: GID-TA11615 Expected publication date: TBC
Awaiting development Reference number: GID-TA11639 Expected publication date: TBC